ORTEXORTEX News
Tracking MTW? Get live short interest, options flow, and signals on ORTEX.Sign up free →
MT
Trader NoteMTW

MTW Reports Q3 After Shorts Built, Buyers Held Firm

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 4 Nov 2026, 18:32

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

The Manitowoc Company heads into its Q3 earnings release with a striking split: short sellers spent October adding aggressively, yet the stock still closed the week 5.7% higher at $23.80.

The positioning story has shifted somewhat since yesterday's earnings preview. Short interest has eased fractionally in the latest reading, down 0.15% on the day to 5.1% of the free float, after the month-on-month build of nearly 48% that defined October. The borrow market offers no impediment to further short activity: availability is extremely loose at 2,839%, meaning there are roughly 28 shares available to lend for every one already borrowed, and cost to borrow has dropped sharply to 0.40%, down 39% on the week. That combination tells you the short build in October was a conviction call, not a forced or opportunistic trade enabled by tightening supply. Options positioning remains calm. The put/call ratio of 0.16 is in line with its 20-day average of 0.17 and sits near the lower end of the 52-week range, with a z-score of minus 0.35. No defensive hedging spike preceded the print.

The Street's view of Manitowoc is a clear negative, though the analyst data is now approximately three months stale and should be read as background context rather than current opinion. Both Wells Fargo and Barclays maintained Underweight ratings in August, with targets of $12 and $16 respectively, well below the current price of $23.80. Even Baird and UBS, which carry Neutral ratings, last set targets in a range that implies the stock has significantly overshot what analysts modelled. The ORTEX earnings yield factor ranks in the 70th percentile, reflecting some fundamental support, and the EPS surprise factor is an exceptional 97th percentile, meaning the company has consistently beaten estimates at a rate almost unmatched in the universe. That track record is precisely the kind of thing that could keep buyers engaged even as sell-side targets lag the price action.

The earnings history adds texture here. The most recent comparable data point, the August 2026 Q2 print, produced a one-day move of plus 33% and a five-day move of plus 46%. That was an extraordinary reaction, and it has almost certainly contributed to the short build: traders anticipating mean reversion in the magnitude of post-earnings moves were adding exposure through October at prices well above where analysts set their targets. Whether the Q3 result repeats anything like that magnitude of move is what every position on the board is now priced around.

Among peers, TEX on NYSE rose 15.8% on the week, more than doubling MTW's gain, while ALSN added 10.4%. PKOH on Nasdaq was essentially flat, down 0.7%. The industrial machinery complex broadly had a good week, which removes some of the idiosyncratic signal from MTW's move. Institutional ownership is led by BlackRock at 11.3% of shares, with Dimensional and Vanguard also sizeable holders, so any post-earnings re-rating will have to move genuine institutional paper rather than just float.

The number to watch now is whether the Q3 result sustains the EPS surprise streak that ranks in the 97th percentile, and whether short sellers who built through October hold positions or cover into the reaction.

Stocks in this article

See the live data behind this article on ORTEX.

Open MTW on ORTEX →

How this article was generated

Generated
4 Nov 2026, 18:36
Data as of
4 Nov 2026, 18:32
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.